http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0248088-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 |
| filingDate | 1986-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_461b78758451b02fbf61acff051b8327 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1de911ae1b09f29898bfa01ed72727b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1812de1738581758a31595177818049a |
| publicationDate | 1987-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0248088-A1 |
| titleOfInvention | Vascularization factor and process for its preparation |
| abstract | A vascularization factor which can be yielded by endothelial cells of a blood vessel, which is absorbed by an agarose gel having heparin immobilized thereon and is eluted by 0.7 M to 1.0 M sodium chloride, which is adsorbed by a diethylaminoethyl anion exchanger and is eluted by 0.2 M to 0.4 M sodium chloride, and which has a molecular weight of about 5,000 to 10,000. This factor can be utilized in treating ischemic diseases and wounds. |
| priorityDate | 1985-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.